An interventional study of Thinkific Prehabilitation Exercise Program in Prehabilitation, Oncology and Surgical Oncology, sponsored by MaineHealth. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-24.
Sponsored by MaineHealth · Not applicable, Interventional, and Prevention
Frailty is a state of increased vulnerability to stressors with increased rates of poor outcomes. Surgery is one of these stressors, and previous research has therefore shown increased rates of morbidity and mortality in frail patients undergoing surgery. Prehabilitation programs can help mitigate the negative outcomes associated with frailty. The investigators hope to implement a newly developed prehabilitation pilot program in the Maine Medical Center Surgical Oncology Clinic to initially evaluate adherence, self-efficacy, and health-related quality of life.
Frailty is a state of increased vulnerability to stressors with increased rates of poor outcomes. Surgery is one of these stressors, and previous research has therefore shown increased rates of morbidity and mortality in frail patients undergoing surgery. Prehabilitation programs can help mitigate the negative outcomes associated with frailty. The investigators hope to implement a newly developed prehabilitation pilot program in the Maine Medical Center Surgical Oncology Clinic to initially evaluate adherence, self-efficacy, and health-related quality of life.
The investigators now hope to implement this prehabilitation program in the clinics at Maine Medical Center. Our long term goal is the introduce this program in all surgical specialties; but first, the investigators plan to assess adherence, patient self-efficacy, frailty and health-related quality of life through a pilot study in the surgical oncology clinic.
9,617 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.
This study's planned enrollment of 20 is below the median of 50 across 7,432 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →MaineHealth is the lead sponsor of 36 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients enrolled in this arm will receive the preabilitation intervention program prior to their surgery to complete
Other: Thinkific Prehabilitation Exercise Program
Prehabilitation exercise program through the Thinkific platform
Participant adherence to prehab program
Evaluate adherence through analysis of patient maintained exercise logs via number of days completed
Time frame: Through study completion, on average 3 months
Correlation between patient pre-program self-efficacy evaluation and measured adherence to study prehabilitation program
Assess self-efficacy by evaluating the relationship between pre-program Self-Efficacy for Home Exercise Program Scale (0-72) score and adherence.
Time frame: Through study completion, on average 3 months
Patient Satisfaction
Assess patient satisfaction and barriers to adherence through a post prehab program survey.
Time frame: Last day of prehabilitation program (within week prior to surgery)
Quality of Life (Short Form- 36 Survey)
Evaluate change in health-related quality of life before and after participation in the prehabilitation program.
Time frame: Completed at Day 0, Two weeks, Four weeks and Last day of prehabilitation program (within week prior to surgery)
Frailty (Risk Analysis Index)
Evaluate change in frailty using Risk Analysis Index before and after participation in the prehabilitation program.
Time frame: Evaluated on Day 0 and at last visit prior to surgery, an average of 3 months
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
Started Jun 2022 (actual). Primary completion is estimated for Jun 2024, 24 months after the start.
Of 1,358 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 71. This study's planned 24 months is below that.
Counting every sponsor, half of 1,404 studies reached it within 38 months; a quarter within 17 and three quarters within 71.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
MaineHealth